What Does a Sleep Study System Cost?

Capital outlay, per-unit device pricing, and total-cost-of-ownership for polysomnography labs and home sleep testing fleets — based on publicly available data. MedSource has not yet accumulated aggregate quote data for this category; pricing will be updated as vendor submissions accrue.

---

Sleep study systems span two distinct procurement categories with very different capital profiles. A full in-lab polysomnography (PSG) lab build-out — covering acquisition of multi-channel amplifier/headbox units, software workstations, and supporting infrastructure — runs $200,000–$400,000 in initial equipment outlay for a 4-bed configuration (polysomnography machines, beds, monitors). At the other end, a fleet of Level III home sleep apnea testing (HSAT) devices can be assembled for far less per unit, though device list prices from major manufacturers (Cadwell, Natus/Nox Medical, Itamar WatchPAT, ResMed) are not published on public price lists, and GSA Schedule pricing for this category was not identified at time of publication. What drives the range: AASM-mandated channel count, ambulatory versus in-lab form factor, software licensing model, and whether CPAP titration capability is bundled.

---

What the Typical Range Is

In-Lab PSG Systems (Level 1)

The standard PSG protocol includes EEG, EOG, ECG, submental and limb EMG, measurements of airflow, respiration, and blood oxygenation, plus audiovisual data collection. The standard for each room is one polysomnograph with at least 10 channels capable of continuous monitoring. Systems meeting this specification — such as the Cadwell Easy III, Natus Embla N7000, Löwenstein Somno HD, or Compumedics Grael — are Class II FDA-regulated devices. Publicly listed capital costs per bed are not widely published; however, a 4-bed sleep lab equipment build-out is estimated at $200,000–$400,000, with annual software and data management running an additional $10,000–$30,000. That implies a per-bed equipment cost of roughly $50,000–$100,000 before software, though that range is derived from aggregate lab-setup estimates, not verified manufacturer list prices.

Home Sleep Apnea Testing (HSAT) Devices (Level III/IV)

A Level III HST device records a minimum of four channels — heart rate, airflow, respiratory effort, and oxygen saturation — and is typically more expensive than a Level IV device, which measures fewer parameters. The WatchPAT (Itamar Medical), Nox T3, ResMed ApneaLink Air, and Embletta X100 are frequently referenced in clinical literature. Cardiorespiratory home study using an Embletta X10 collects thermistor, pressure transducer, chest and abdominal effort, body position, heart rate, and oxygen saturation channels. Published per-unit device list prices are not available from manufacturer websites; the secondary/refurbished market on platforms such as Bimedis shows used polysomnograph units ranging from approximately $60 to $9,220, with an average across 16 listings of roughly $2,962 — though this market reflects mixed generations and international sellers and should not be used as a proxy for new-equipment list pricing.

---

What Pushes Price Up

• Channel count and modularity. Systems such as the SOMNO HD offer 55 channels (10 internal, 28 external, 17 EXG via headbox), upgradeable to 70 channels — a configuration targeting complex cases involving seizure monitoring or REM behavior disorder. High channel count directly increases headbox cost and software licensing tiers.
• CPAP titration integration. Systems that support real-time CPAP/BiPAP titration during a split-night protocol require additional hardware interfaces and typically carry a software add-on fee.
• Video surveillance integration. Some machines are equipped with a video camera to associate physiological data with a visual record of subject behavior , adding both hardware cost and HIPAA-compliant storage requirements.
• AASM accreditation compliance. Facilities seeking accreditation from the American Academy of Sleep Medicine must meet equipment standards (including minimum channel count and signal quality specifications per AASM scoring rules) that effectively exclude lower-tier units.
• IEC 60601-1 / FDA 510(k) clearance. Devices with current FDA 510(k) clearance and IEC 60601-1 electrical safety certification command a premium over non-cleared alternatives, which matters when facilities require documented regulatory compliance for Joint Commission review.

---

What Pushes Price Down

• Refurbished units. Secondary-market PSG systems from biomedical equipment resellers can reduce per-unit acquisition cost significantly; however, software license transfer fees, electrode compatibility, and firmware support windows must be verified before purchase.
• HSAT vs. full PSG deployment. In a 2013 survey of sleep centers, 64% reported offering HST for privately insured patients, and 48% reported reducing their plans for expansion of laboratory beds as a result of home testing. Facilities that shift diagnostic volume to Level III HSAT devices avoid the capital cost of dedicated sleep lab beds.
• Bundled fleet purchases. Manufacturers typically offer volume pricing when a facility orders 10+ HSAT units. Specific discount tiers are not publicly posted but are negotiable.
• GPO contracts. Premier, Vizient, and HealthTrust list medical capital equipment contracts; whether PSG-specific SKUs are currently on these schedules requires direct GPO portal verification, as sleep diagnostic equipment contracts cycle in and out.
• Older-generation hardware. Prior-generation amplifiers (e.g., Embla S4500 vs. current N7000) can still meet AASM channel requirements and may be available through trade-in programs at meaningful discounts.

---

Hidden Costs

Beyond capital equipment, a 4-bed PSG lab carries annual staffing costs of $250,000–$400,000 (sleep technicians, physicians, administrative staff), facility costs of $50,000–$100,000, and consumables (electrodes, sensors, cleaning materials) of $20,000–$40,000. Procurement officers should model these separately from device capital:

• Disposable electrodes and sensors. Gold-cup EEG electrodes, piezoelectric respiratory belts, pulse oximetry finger probes, and submental EMG leads are per-study consumables. Costs vary by brand compatibility; proprietary sensor ecosystems (a common vendor strategy) can lock facilities into single-source purchasing.
• Software licensing and annual maintenance. Most PSG platforms charge annual software maintenance fees (typically 15–20% of software list price) covering scoring algorithm updates and AASM rule-set revisions.
• Technical training and RPSGT credentialing support. A trained PSG technologist typically requires a 30-minute patient instruction session per home study — and initial lab staff training on new platforms routinely requires 1–2 days of vendor-provided on-site instruction, sometimes billed separately from the equipment contract.
• Biomedical calibration. PSG amplifiers require periodic impedance and signal calibration checks. If the facility's biomedical engineering department is not equipped, third-party service contracts add cost.
• Network and data storage. Platforms that allow live recording access and data storage via Citrix or cloud infrastructure introduce annual IT licensing and HIPAA-compliant storage costs that are often off the biomedical budget but real total-cost-of-ownership items.

---

How to Negotiate

1. Separate hardware, software, and service line items. Vendors routinely bundle these into a single capital quote. Requiring itemized pricing reveals where margin sits — software licensing and service contracts are typically the highest-margin components.
2. Request a trade-in credit for legacy amplifiers. If replacing older-generation units, manufacturers and authorized resellers will often apply a trade-in offset, especially during fiscal year-end purchasing windows (typically Q4 for most manufacturers).
3. Benchmark against reimbursement rates. Because in-lab PSG requires intensive staffing, specialized facility, and comprehensive data collection including EEG, the total charge for an in-lab PSG generally ranges from $3,000 to $5,000 per study. A capital equipment ROI model — number of studies per year × net reimbursement — gives your facility a defensible ceiling price when negotiating acquisition cost.
4. Negotiate HSAT fleet pricing by total volume, not per-unit. For programs deploying reusable Level III devices, a fleet of 20–30 units with a single vendor creates leverage for meaningful per-unit discounts and favorable accessory pricing.
5. Pin down software upgrade commitments in writing. AASM scoring rules and CMS reimbursement criteria for sleep studies have been revised multiple times. Contracts should specify whether future AASM-rule software updates are included in annual maintenance fees or billed separately.

---

When the Price Feels Off

• A new full-channel PSG system quoted under $15,000 per bed. Unless it is a stripped-down portable unit with limited channel counts, a price this low warrants careful review of FDA clearance status, channel specifications, and software completeness.
• No itemized software licensing cost. Perpetual-license claims without annual maintenance fees are uncommon for clinical PSG software; verify upgrade and support terms contractually.
• HSAT devices without FDA 510(k) clearance. The devices used for at-home sleep studies are FDA-approved ; any HSAT device offered without verifiable 510(k) clearance number creates regulatory exposure for the ordering facility.
• Service contracts priced above 20% of hardware list price annually. Industry norms for medical equipment service contracts run 10–18% of capital cost per year; above 20% without on-site response time guarantees and parts coverage warrants pushback.
• "All-in" quotes that exclude electrode consumables. A first-year consumable cost that was omitted from the capital quote can represent $5,000–$15,000 in unplanned operating expense for a multi-bed lab.

---

Sources

1. droracle.ai — Estimated cost of operating a 4-bed PSG sleep laboratory (February 2025). Aggregate equipment and operational cost estimates.
2. PMC / Sleep and Breathing (2017) — Tymofiyeva et al., "Investigating Cost Implications of Incorporating Level III At-Home Testing into a Polysomnography Based Sleep Medicine Program Using Administrative Data." PMC5534303.
3. Biology Insights / PMC (2015) — "An Economic Evaluation of Home Versus Laboratory-Based Diagnosis of Obstructive Sleep Apnea." PMC4481018.
4. MedicalExpo / Cadwell / Bimedis — Manufacturer product listings (Cadwell Easy III, SOMNO HD, Löwenstein Sonata); secondary market pricing (Bimedis polysomnograph listings, accessed 2025).

Data notice: MedSource has not yet collected aggregated quote data for Sleep Study Systems. The ranges above are derived from publicly available lab-setup estimates, clinical literature, and secondary market listings — not from direct manufacturer RFQ responses. This article will be updated as quote data accrues. If you have recently completed a PSG or HSAT procurement, consider submitting your pricing data to help benchmark this category.